Mechanisms in the regulation of aromatase in developing ovary and placenta

Carole R. Mendelson, Amrita Kamat

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

During human gestation, the placental syncytiotrophoblast develops the capacity to synthesize large amounts of estrogen from C19-steroids secreted by the fetal adrenals. The conversion of C19-steroids to estrogens is catalyzed by aromatase P450 (P450arom), product of the CYP19 gene. The placenta-specific promoter of the hCYP19 gene lies ∼100,000 bp upstream of the translation initiation site in exon II. In studies using transgenic mice and transfected human trophoblast cells we have defined a 246-bp region upstream of placenta-specific exon I.1 that mediates placental cell-specific expression. Using transgenic mice, we also observed that as little as 278 bp of DNA flanking the 5′-end of ovary-specific hCYP19 exon IIa was sufficient to target ovary-specific expression. This ovary-specific promoter contains response elements that bind cAMP-response element-binding protein (CREB) and the orphan nuclear receptors SF-1 and LRH-1, which are required for cAMP-mediated stimulation of CYP19 expression in granulosa and luteal cells during the estrous cycle and pregnancy. In this article, we review our studies to define genomic regions and response elements that mediate placenta-specific expression of the hCYP19 gene. The temporal and spatial expression of LRH-1 versus SF-1 in the developing gonad during mouse embryogenesis and in the postnatal ovary also will be considered.

Original languageEnglish (US)
Pages (from-to)62-70
Number of pages9
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume106
Issue number1-5
DOIs
StatePublished - Aug 2007

Fingerprint

Aromatase
Placenta
Ovary
Exons
Genes
Response Elements
Estrogens
Trophoblasts
Steroids
Orphan Nuclear Receptors
Transgenic Mice
Cyclic AMP Response Element-Binding Protein
Luteal Cells
Pregnancy
Estrous Cycle
Gonads
Embryonic Development
DNA
Gene Expression

Keywords

  • Estrogen biosynthesis
  • Human CYP19 gene
  • Liver receptor homologue-1 (LRH-1)
  • Ovary
  • Placenta
  • Steroidogenic factor-1 (SF-1)
  • Tissue-specific expression

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Mechanisms in the regulation of aromatase in developing ovary and placenta. / Mendelson, Carole R.; Kamat, Amrita.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 106, No. 1-5, 08.2007, p. 62-70.

Research output: Contribution to journalArticle

@article{e5ff2043eedc483cb4efe8222903c123,
title = "Mechanisms in the regulation of aromatase in developing ovary and placenta",
abstract = "During human gestation, the placental syncytiotrophoblast develops the capacity to synthesize large amounts of estrogen from C19-steroids secreted by the fetal adrenals. The conversion of C19-steroids to estrogens is catalyzed by aromatase P450 (P450arom), product of the CYP19 gene. The placenta-specific promoter of the hCYP19 gene lies ∼100,000 bp upstream of the translation initiation site in exon II. In studies using transgenic mice and transfected human trophoblast cells we have defined a 246-bp region upstream of placenta-specific exon I.1 that mediates placental cell-specific expression. Using transgenic mice, we also observed that as little as 278 bp of DNA flanking the 5′-end of ovary-specific hCYP19 exon IIa was sufficient to target ovary-specific expression. This ovary-specific promoter contains response elements that bind cAMP-response element-binding protein (CREB) and the orphan nuclear receptors SF-1 and LRH-1, which are required for cAMP-mediated stimulation of CYP19 expression in granulosa and luteal cells during the estrous cycle and pregnancy. In this article, we review our studies to define genomic regions and response elements that mediate placenta-specific expression of the hCYP19 gene. The temporal and spatial expression of LRH-1 versus SF-1 in the developing gonad during mouse embryogenesis and in the postnatal ovary also will be considered.",
keywords = "Estrogen biosynthesis, Human CYP19 gene, Liver receptor homologue-1 (LRH-1), Ovary, Placenta, Steroidogenic factor-1 (SF-1), Tissue-specific expression",
author = "Mendelson, {Carole R.} and Amrita Kamat",
year = "2007",
month = "8",
doi = "10.1016/j.jsbmb.2007.05.001",
language = "English (US)",
volume = "106",
pages = "62--70",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "1-5",

}

TY - JOUR

T1 - Mechanisms in the regulation of aromatase in developing ovary and placenta

AU - Mendelson, Carole R.

AU - Kamat, Amrita

PY - 2007/8

Y1 - 2007/8

N2 - During human gestation, the placental syncytiotrophoblast develops the capacity to synthesize large amounts of estrogen from C19-steroids secreted by the fetal adrenals. The conversion of C19-steroids to estrogens is catalyzed by aromatase P450 (P450arom), product of the CYP19 gene. The placenta-specific promoter of the hCYP19 gene lies ∼100,000 bp upstream of the translation initiation site in exon II. In studies using transgenic mice and transfected human trophoblast cells we have defined a 246-bp region upstream of placenta-specific exon I.1 that mediates placental cell-specific expression. Using transgenic mice, we also observed that as little as 278 bp of DNA flanking the 5′-end of ovary-specific hCYP19 exon IIa was sufficient to target ovary-specific expression. This ovary-specific promoter contains response elements that bind cAMP-response element-binding protein (CREB) and the orphan nuclear receptors SF-1 and LRH-1, which are required for cAMP-mediated stimulation of CYP19 expression in granulosa and luteal cells during the estrous cycle and pregnancy. In this article, we review our studies to define genomic regions and response elements that mediate placenta-specific expression of the hCYP19 gene. The temporal and spatial expression of LRH-1 versus SF-1 in the developing gonad during mouse embryogenesis and in the postnatal ovary also will be considered.

AB - During human gestation, the placental syncytiotrophoblast develops the capacity to synthesize large amounts of estrogen from C19-steroids secreted by the fetal adrenals. The conversion of C19-steroids to estrogens is catalyzed by aromatase P450 (P450arom), product of the CYP19 gene. The placenta-specific promoter of the hCYP19 gene lies ∼100,000 bp upstream of the translation initiation site in exon II. In studies using transgenic mice and transfected human trophoblast cells we have defined a 246-bp region upstream of placenta-specific exon I.1 that mediates placental cell-specific expression. Using transgenic mice, we also observed that as little as 278 bp of DNA flanking the 5′-end of ovary-specific hCYP19 exon IIa was sufficient to target ovary-specific expression. This ovary-specific promoter contains response elements that bind cAMP-response element-binding protein (CREB) and the orphan nuclear receptors SF-1 and LRH-1, which are required for cAMP-mediated stimulation of CYP19 expression in granulosa and luteal cells during the estrous cycle and pregnancy. In this article, we review our studies to define genomic regions and response elements that mediate placenta-specific expression of the hCYP19 gene. The temporal and spatial expression of LRH-1 versus SF-1 in the developing gonad during mouse embryogenesis and in the postnatal ovary also will be considered.

KW - Estrogen biosynthesis

KW - Human CYP19 gene

KW - Liver receptor homologue-1 (LRH-1)

KW - Ovary

KW - Placenta

KW - Steroidogenic factor-1 (SF-1)

KW - Tissue-specific expression

UR - http://www.scopus.com/inward/record.url?scp=34548413647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548413647&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2007.05.001

DO - 10.1016/j.jsbmb.2007.05.001

M3 - Article

C2 - 17596931

AN - SCOPUS:34548413647

VL - 106

SP - 62

EP - 70

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 1-5

ER -